Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The Naloxone Component of Buprenorphine/Naloxone: Discouraging Misuse, but at What Cost?
Journal: Journal of addiction medicine
Published: August 01, 2022
Successful Transition from Fentanyl to Buprenorphine in a Community-based Withdrawal Management Setting.
Journal: Journal of addiction medicine
Published: July 21, 2022
Envisioning Minimally Disruptive Opioid Use Disorder Care.
Journal: Journal of general internal medicine
Published: June 10, 2022
Collaboration in a time of crisis: Adapting a telementoring ECHO for addiction leaders during COVID-19.
Journal: Substance abuse
Published: September 14, 2021
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine-Case Reports of Expanding Access to Addiction Treatment During COVID-19.
Journal: Journal of addiction medicine
Published: August 10, 2021
"OPTIONS-DC", a feasible discharge planning conference to expand infection treatment options for people with substance use disorder.
Journal: BMC infectious diseases
Published: March 20, 2021
Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects.
Journal: Journal of substance abuse treatment
Published: June 02, 2020
Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence.
Journal: Journal of the American Board of Family Medicine : JABFM
Published: May 18, 2020
Converging Crises: Caring for Hospitalized Adults With Substance Use Disorder in the Time of COVID-19.
Journal: Journal of hospital medicine
Published: April 26, 2020
Spreading Addictions Care Across Oregon's Rural and Community Hospitals: Mixed-Methods Evaluation of an Interprofessional Telementoring ECHO Program.
Journal: Journal of general internal medicine
Published: April 24, 2020
Last Updated: 09/26/2026